NCT03444402

A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects

A Randomized, Open-label, Multiple-dose, and Three-way Crossover Clinical Trial to Compare Pharmacokinetics and Safety of CKD-381 and D026 in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: Male
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

A Study to compare pharmacokinetics and safety of CKD-381 and D026 in healthy male subjects

Detailed description

A randomized, open-label, multiple-dose, and three-way cross over clinical trial to compare pharmacokinetics and safety of CKD-381 and D026 in healthy male subjects

Conditions

• GERD

Interventions

Type	Name	Description
DRUG	CKD-381(formulation I)	1 tablet administered before the breakfast during 7 days
DRUG	CKD-381(formulation II)	1 tablet administered before the breakfast during 7 days
DRUG	D026(Nexium 40mg)	1 tablet administered before the breakfast during 7 days

Timeline

• Start date: 2018-03-02
• Primary completion: 2018-05-04
• Completion: 2018-05-04
• First posted: 2018-02-23
• Last updated: 2018-05-24

Locations

1 site across 1 country: South Korea